HUM — Humana Inc. stock price and chart

HUM

Humana Inc.Stock · HealthcareS&P 500 Equal Weight 0.3% · S&P 500 0.07% · Russell 1000 0.07% · Russell 3000 0.07% · US Stock Market 0.07% · MSCI World 0.04% · MSCI ACWI 0.03%

$409.80+2.26%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

200.0250.0300.0350.0400.0450.0500.0550.0020.0M$409.80

2026-09-11

Price$409.80

MA20$327.92

MA50$277.67

Vol4.9M

What would $1,000 invested in HUM be worth today? →

HUM returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $409.80
Change YTD: +61.19%
Next earnings: Nov 4, 2026
Market cap: 49.2B2016-09 26.4B2026-09 49.2B+86.6% over the window
Enterprise value: 40.2B
Shares outstanding: 120.1M2016-06 149.1M2026-06 120.1M-19.4% over the window
52W low: $163.11
52W high: $428.88
From 52W high: -4.45%
From 52W low: +151.24%
52W range: 93%
Beta: 0.73

Volume

Rel volume: 0.65×
30D volume: 1M
30D $ vol: 403.4M

Fundamentals

Sales (ttm): 145.7B2016-06 54.5B2026-06 145.7B+167.1% over the window
Sales/share: $1,213.182016-06 $365.812026-06 $1,213.18+231.6% over the window
EPS (ttm): $10.582016-06 $6.502026-06 $10.58+62.8% over the window
FCF (ttm): 1.9B2016-06 1.1B2026-06 1.9B+84.7% over the window
FCF/share: $16.232016-06 $7.082026-06 $16.23+129.3% over the window
Book value/share: $160.002016-06 $72.952026-06 $160.00+119.3% over the window
Net margin: 0.88%2016-06 1.8%2026-06 0.9%-51.1% over the window
ROE: 6.66%2016-06 9.0%2026-06 6.7%-26.1% over the window
ROA: 2.24%2016-06 3.6%2026-06 2.2%-37.9% over the window
Debt / equity: 0.62×2016-06 0.352026-06 0.62+78.7% over the window
Current ratio: 1.742016-06 1.792026-06 1.74-2.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +18.35%2025-06-30 → 2026-06-30123.1B → 145.7B (+18.3% total)+13.84%2023-06-30 → 2026-06-3098.7B → 145.7B (+47.6% total)+12.61%2021-06-30 → 2026-06-3080.5B → 145.7B (+81.1% total)+10.33%2016-06-30 → 2026-06-3054.5B → 145.7B (+167.1% total)
Net income: -18.86%2025-06-30 → 2026-06-301.6B → 1.3B (-18.8% total)-27.65%2023-06-30 → 2026-06-303.4B → 1.3B (-62.1% total)-12.42%2021-06-30 → 2026-06-302.5B → 1.3B (-48.5% total)+2.70%2016-06-30 → 2026-06-30980M → 1.3B (+30.5% total)
FCF: -20.10%2025-06-30 → 2026-06-302.4B → 1.9B (-20.1% total)-45.64%2023-06-30 → 2026-06-3012.1B → 1.9B (-83.9% total)+33.72%2021-06-30 → 2026-06-30456M → 1.9B (+327.4% total)+6.33%2016-06-30 → 2026-06-301.1B → 1.9B (+84.7% total)
Shares: -0.16%2025-06-30 → 2026-06-30120.3M → 120.1M (-0.2% total)-1.04%2023-06-30 → 2026-06-30123.9M → 120.1M (-3.1% total)-1.35%2021-06-30 → 2026-06-30128.5M → 120.1M (-6.6% total)-2.14%2016-06-30 → 2026-06-30149.1M → 120.1M (-19.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -18.92%2025-06-30 → 2026-06-30$13.05 → $10.58 (-18.9% total)-26.62%2023-06-30 → 2026-06-30$26.78 → $10.58 (-60.5% total)-10.96%2021-06-30 → 2026-06-30$18.91 → $10.58 (-44.0% total)+4.99%2016-06-30 → 2026-06-30$6.50 → $10.58 (+62.8% total)
Sales/share: +18.53%2025-06-30 → 2026-06-30$1,023.60 → $1,213.18 (+18.5% total)+15.04%2023-06-30 → 2026-06-30$796.78 → $1,213.18 (+52.3% total)+14.15%2021-06-30 → 2026-06-30$626.05 → $1,213.18 (+93.8% total)+12.74%2016-06-30 → 2026-06-30$365.81 → $1,213.18 (+231.6% total)
FCF/share: -19.97%2025-06-30 → 2026-06-30$20.28 → $16.23 (-20.0% total)-45.07%2023-06-30 → 2026-06-30$97.97 → $16.23 (-83.4% total)+35.54%2021-06-30 → 2026-06-30$3.55 → $16.23 (+357.4% total)+8.66%2016-06-30 → 2026-06-30$7.08 → $16.23 (+129.3% total)
Book value/share: +5.54%2025-06-30 → 2026-06-30$151.61 → $160.00 (+5.5% total)+5.60%2023-06-30 → 2026-06-30$135.86 → $160.00 (+17.8% total)+6.74%2021-06-30 → 2026-06-30$115.51 → $160.00 (+38.5% total)+8.17%2016-06-30 → 2026-06-30$72.95 → $160.00 (+119.3% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$3.54 → $3.54 (+0.0% total)+4.26%2022-12-31 → 2026-06-30$3.06 → $3.54 (+15.7% total)+6.00%2021-06-30 → 2026-06-30$2.65 → $3.54 (+33.8% total)+11.80%2016-06-30 → 2026-06-30$1.16 → $3.54 (+205.2% total)
Price: +47.07%2025-09-11 → 2026-09-11$278.72 → $409.80 (+47.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.27%2023-09-11 → 2026-09-11$467.18 → $409.80 (-12.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.39%2021-09-10 → 2026-09-11$401.98 → $409.80 (+1.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.78%2016-09-09 → 2026-09-11$176.50 → $409.80 (+132.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +49.19%2025-09-11 → 2026-09-11$274.76 → $409.80 (+49.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-3.11%2023-09-11 → 2026-09-11$450.52 → $409.80 (-9.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.39%2021-09-10 → 2026-09-11$382.37 → $409.80 (+7.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.71%2016-09-09 → 2026-09-11$162.17 → $409.80 (+152.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 38.7×2016-09 23.632026-09 38.48+62.8% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 18.2×2016-09 10.692026-09 18.19+70.2% over the window
Fwd P/E: 24.2×
P/S (ttm)Market cap ÷ TTM revenue.: 0.3×2016-09 0.482026-09 0.34-29.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.6×2016-09 2.342026-09 2.56+9.6% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 25.2×2016-09 5.852026-09 25.25+332.0% over the window
EV/EBITDA (fy): 11.9×
EV/Sales (ttm): 0.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.96%2016-06 4.0%2026-06 4.1%+2.5% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.86%
Dividend/share (fwd): $3.54
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 120.1M ÷ 120.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 0.16%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (0.16%) + dividends paid over that year ($430M) ÷ market_cap_at(2025-06-30) ($29.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 1.62%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($150M) ÷ today's market cap ($49.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.30%2016-06 0.3%2026-06 0.3%-4.3% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $150M + TTM dividends $430M) ÷ today's market cap ($49.2B). Same caveat as the cash buyback yield.: 1.18%2016-06 1.0%2026-06 1.2%+22.4% over the window

Vs own 10Y history

P/E: 96th
P/OI: 92nd
P/S: 19th
P/B: 23rd
P/FCF: 78th

Bar = where today’s multiple sits in HUM’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+2.26%

+0.81%

+5.39%

+11.41%

YTD

+61.19%

+51.95%

+3.52%

Financial statements

Open full HUM financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Humana Inc. (HUM) trades at $409.80 with a live price and an interactive chart covering 44+ years of daily price history, plus key valuation metrics. ChartRow also publishes HUM’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full HUM financial statements →

HUM — Humana Inc. price, chart and key statistics